Search research articles
Contact Us
Filters
Showing results (11-20 of 178) with videos related to
Page
of 18
Sort By:
Nature Biotechnology
|
January 10, 2015
Modeling the course of amyotrophic lateral sclerosis
Christina Fournier, Jonathan D Glass
The Journal of Clinical Investigation
|
October 21, 2009
The APCs of neuroprotection
Charles T Esmon, Jonathan D Glass
JAMA Neurology
|
January 10, 2022
Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?
Jonathan D Glass, Christina N Fournier
Neuro-Degenerative Diseases
|
October 16, 2007
Axonal degeneration in motor neuron disease
Lindsey R Fischer, Jonathan D Glass
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199
Christina N Fournier, Jonathan D Glass
Acta Neuropathologica
|
December 30, 2009
Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures
Lindsey R Fischer, Jonathan D Glass
Neurology
|
May 2, 2007
Selecting promising ALS therapies in clinical trials
Jonathan D Glass, Michael Benatar, Meraida Polak
Mutation Research
|
April 26, 2003
Stable inheritance of an 85-kb triplication in C57BL/WldS mice
Weiqian Mi, Jonathan D Glass, Michael P Coleman
The New England Journal of Medicine
|
September 25, 2002
Poliomyelitis due to West Nile virus
Jonathan D Glass, Owen Samuels, Mark M Rich
Neurology
|
September 19, 2018
Reader response: Pathologic Thr
Jonathan D Glass, Christina N Fournier, Marla Gearing
Page
of 18
Search research articles
Search
Showing results (11-20 of 178) with videos related to
Sort By:
Page
of 18
Nature Biotechnology
|
January 10, 2015
Modeling the course of amyotrophic lateral sclerosis
Christina Fournier, Jonathan D Glass
The Journal of Clinical Investigation
|
October 21, 2009
The APCs of neuroprotection
Charles T Esmon, Jonathan D Glass
JAMA Neurology
|
January 10, 2022
Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?
Jonathan D Glass, Christina N Fournier
Neuro-Degenerative Diseases
|
October 16, 2007
Axonal degeneration in motor neuron disease
Lindsey R Fischer, Jonathan D Glass
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199
Christina N Fournier, Jonathan D Glass
Acta Neuropathologica
|
December 30, 2009
Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures
Lindsey R Fischer, Jonathan D Glass
Neurology
|
May 2, 2007
Selecting promising ALS therapies in clinical trials
Jonathan D Glass, Michael Benatar, Meraida Polak
Mutation Research
|
April 26, 2003
Stable inheritance of an 85-kb triplication in C57BL/WldS mice
Weiqian Mi, Jonathan D Glass, Michael P Coleman
The New England Journal of Medicine
|
September 25, 2002
Poliomyelitis due to West Nile virus
Jonathan D Glass, Owen Samuels, Mark M Rich
Neurology
|
September 19, 2018
Reader response: Pathologic Thr
Jonathan D Glass, Christina N Fournier, Marla Gearing
Page
of 18